Stock Analysis on Net

Pfizer Inc. (NYSE:PFE)

Market Value Added (MVA)

Microsoft Excel

MVA

Pfizer Inc., MVA calculation

US$ in millions

Microsoft Excel
Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Fair value of debt1 71,350 32,945 44,241 48,236 57,037
Operating lease liability 3,153 3,217 2,959 1,435 1,324
Market value of common equity 155,569 237,687 258,449 188,635 189,174
Preferred stock, no par value, at stated value 17
Equity attributable to noncontrolling interests 274 255 261 235 304
Less: Marketable securities 12,813 25,552 33,556 13,411 10,783
Market (fair) value of Pfizer 217,533 248,552 272,354 225,130 237,073
Less: Invested capital2 154,882 110,746 87,670 103,898 120,978
MVA 62,651 137,806 184,684 121,232 116,095

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

1 Fair value of debt. See details »

2 Invested capital. See details »

Item Description The company
MVA Pfizer Inc. market (fair) value less invested capital. Pfizer Inc. MVA decreased from 2021 to 2022 and from 2022 to 2023.

MVA Spread Ratio

Pfizer Inc., MVA spread ratio calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Selected Financial Data (US$ in millions)
Market value added (MVA)1 62,651 137,806 184,684 121,232 116,095
Invested capital2 154,882 110,746 87,670 103,898 120,978
Performance Ratio
MVA spread ratio3 40.45% 124.43% 210.66% 116.68% 95.96%
Benchmarks
MVA Spread Ratio, Competitors4
AbbVie Inc. 438.96% 297.39% 253.64% 172.70% 236.51%
Amgen Inc. 207.91% 308.27% 303.88% 343.98% 341.92%
Bristol-Myers Squibb Co. 100.64% 160.91% 138.81% 109.83% 90.05%
Danaher Corp. 157.62% 156.95% 187.44% 172.97% 135.15%
Eli Lilly & Co. 2,389.96% 1,239.79% 833.40% 778.02% 601.09%
Gilead Sciences Inc. 148.05% 175.26% 119.58% 125.56% 226.14%
Johnson & Johnson 309.06% 288.03% 366.17% 363.07% 335.85%
Merck & Co. Inc. 412.35% 312.72% 223.02% 292.93% 328.56%
Moderna Inc. 426.77% 461.14% 378.45% 1,322.35% 1,719.94%
Regeneron Pharmaceuticals Inc. 663.41% 521.52% 461.61% 508.24% 460.29%
Thermo Fisher Scientific Inc. 189.49% 195.28% 211.22% 232.26% 171.11%

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

1 MVA. See details »

2 Invested capital. See details »

3 2023 Calculation
MVA spread ratio = 100 × MVA ÷ Invested capital
= 100 × 62,651 ÷ 154,882 = 40.45%

4 Click competitor name to see calculations.

Performance ratio Description The company
MVA spread ratio The ratio of MVA to invested capital. It measures the efficiency with which investors’ capital investment has translated into a franchise value and into an aggregate net present value premium. Pfizer Inc. MVA spread ratio deteriorated from 2021 to 2022 and from 2022 to 2023.

MVA Margin

Pfizer Inc., MVA margin calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Selected Financial Data (US$ in millions)
Market value added (MVA)1 62,651 137,806 184,684 121,232 116,095
Revenues 58,496 100,330 81,288 41,908 51,750
Performance Ratio
MVA margin2 107.10% 137.35% 227.20% 289.28% 224.34%
Benchmarks
MVA Margin, Competitors3
AbbVie Inc. 551.18% 420.74% 432.93% 391.08% 446.12%
Amgen Inc. 540.65% 493.74% 503.37% 550.26% 575.79%
Bristol-Myers Squibb Co. 151.08% 250.01% 240.26% 232.86% 345.41%
Danaher Corp. 517.54% 389.99% 468.46% 507.10% 438.18%
Eli Lilly & Co. 2,058.21% 1,055.66% 769.29% 778.57% 578.77%
Gilead Sciences Inc. 251.89% 295.97% 211.56% 259.24% 321.38%
Johnson & Johnson 359.73% 345.62% 383.46% 432.99% 396.88%
Merck & Co. Inc. 479.92% 390.05% 323.90% 349.01% 376.50%
Moderna Inc. 487.11% 230.15% 197.41% 1,368.57%
Regeneron Pharmaceuticals Inc. 605.08% 525.04% 312.14% 495.20% 382.11%
Thermo Fisher Scientific Inc. 378.46% 360.17% 431.35% 441.03% 352.63%

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

1 MVA. See details »

2 2023 Calculation
MVA margin = 100 × MVA ÷ Revenues
= 100 × 62,651 ÷ 58,496 = 107.10%

3 Click competitor name to see calculations.

Performance ratio Description The company
MVA margin The ratio of MVA to sales. It measures how efficiently and prodigiously sales translate into franchise value. Pfizer Inc. MVA margin ratio deteriorated from 2021 to 2022 and from 2022 to 2023.